FISHER-TITUS MEDICAL CENTER — History
CCN 360065 | 3-year financial timeline | COVID resilience: 39/100
🛡️ Public data only — no PHI permitted on this instance.
$148M
Latest Revenue (FY2022)
+4.2%
Revenue CAGR (3yr)
-6.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $137M | $158M | $148M | -6.3% | +4.2% |
| Operating Expenses | $128M | $156M | $158M | +1.8% | +11.3% |
| Operating Margin | 6.4% | 1.7% | -6.9% | -505.6% | +0.0% |
| Net Income | $9M | $3M | $-10M | -480.0% | +0.0% |
| Licensed Beds | 78 | 78 | 78 | +0.0% | +0.0% |
| Total Patient Days | 11,154 | 13,218 | 10,951 | -17.2% | -0.9% |
| Medicare Day % | 36% | 32% | 32% | +1.1% | -5.6% |
| Medicaid Day % | 8% | 4% | 6% | +51.3% | -8.9% |
COVID Impact & Recovery
Resilience Score: 39/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: +8.6% ($137M → $148M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+4.2%
This Hospital
+7.6%
State Avg
Latest Margin
-6.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $154M | -13.5% |
| FY2024 (proj) | $160M | -20.1% |
| FY2025 (proj) | $166M | -26.8% |